IRIS
FRANCHINA, Tindara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 262
NA - Nord America 42
AS - Asia 31
Totale 335
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 117
IE - Irlanda 76
US - Stati Uniti d'America 41
FR - Francia 31
PL - Polonia 26
VN - Vietnam 26
DE - Germania 7
FI - Finlandia 2
GB - Regno Unito 2
IN - India 2
CA - Canada 1
CN - Cina 1
JP - Giappone 1
LU - Lussemburgo 1
SG - Singapore 1
Totale 335
Salva come PNG Salva come JPEG
Città #
Dublin 76
Messina 70
Dong Ket 26
Warsaw 26
Ashburn 9
Columbus 9
Boardman 6
Paris 3
Bremen 2
Council Bluffs 2
Florence 2
Helsinki 2
London 2
Los Angeles 2
Mountain View 2
Scandicci 2
Alassio 1
Duncan 1
Hyderabad 1
Linguaglossa 1
Luxembourg 1
Mascalucia 1
Milan 1
Milpitas 1
Mumbai 1
New York 1
Ottawa 1
Redmond 1
Rome 1
Somerville 1
Tübingen 1
Villeneuve-le-roi 1
Washington 1
Totale 258
Salva come PNG Salva come JPEG
Nome #
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives, file de3e52af-95d1-762d-e053-3705fe0a30e0 32
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario, file de3e52b3-17ae-762d-e053-3705fe0a30e0 32
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients, file de3e52af-8d9f-762d-e053-3705fe0a30e0 28
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going, file de3e52b1-5772-762d-e053-3705fe0a30e0 21
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review, file de3e52b1-5302-762d-e053-3705fe0a30e0 19
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer, file de3e52b3-2091-762d-e053-3705fe0a30e0 19
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer, file de3e52b3-6673-762d-e053-3705fe0a30e0 18
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel, file de3e52b3-6c91-762d-e053-3705fe0a30e0 18
Nab-paclitaxel and trastuzumab combination: A promising approach for neoadjuvant treatment in HER2-positive breast cancer, file de3e52b0-d488-762d-e053-3705fe0a30e0 15
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status, file de3e52b0-d883-762d-e053-3705fe0a30e0 15
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site, file de3e52b3-8d6a-762d-e053-3705fe0a30e0 15
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer, file de3e52b0-d34d-762d-e053-3705fe0a30e0 14
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology, file de3e52b3-0d43-762d-e053-3705fe0a30e0 13
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients, file de3e52b3-a3c6-762d-e053-3705fe0a30e0 12
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation, file de3e52b1-5775-762d-e053-3705fe0a30e0 10
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database, file b0530120-8b4c-4c3b-8603-72ba708a196b 9
Rare histotypes of epithelial biliary tract tumors: A literature review, file a65e5192-dab6-4ce9-accc-daebaade94c3 6
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going, file de3e52b3-6268-762d-e053-3705fe0a30e0 6
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper, file 684ff4c7-1892-4b6e-b554-d4dc2a2b0b97 5
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC)., file de3e52af-9acb-762d-e053-3705fe0a30e0 5
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer, file de3e52b1-4ef4-762d-e053-3705fe0a30e0 4
IL-33/IL-31 axis: A new pathological mechanism for epidermal growth factor receptor tyrosine kinase inhibitors-associated skin toxicity?, file de3e52af-d969-762d-e053-3705fe0a30e0 3
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study, file 1d416ca8-ee13-4929-bd9a-b35b3ac8328c 2
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer., file de3e52b0-fe80-762d-e053-3705fe0a30e0 2
null, file de3e52b1-46e1-762d-e053-3705fe0a30e0 2
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation, file de3e52b3-5312-762d-e053-3705fe0a30e0 2
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer, file de3e52b3-5428-762d-e053-3705fe0a30e0 2
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine, file 10b1360f-d8ca-43b1-8c72-4742b0bea264 1
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines, file ab764e0e-916e-40e3-8f6f-6772c23ef9c4 1
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines, file acb2476c-ee29-4656-bc30-dbcff3c8a737 1
Emerging targeted therapies for castration-resistant prostate cancer, file de3e52b1-0513-762d-e053-3705fe0a30e0 1
null, file de3e52b3-0a3d-762d-e053-3705fe0a30e0 1
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy, file de3e52b3-0dcb-762d-e053-3705fe0a30e0 1
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance, file de3e52b3-8fb7-762d-e053-3705fe0a30e0 1
Totale 336
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 0 0 2 0 11 17
2020/2021101 7 0 4 5 5 1 3 1 7 40 2 26
2021/20229 0 0 0 0 3 2 3 0 0 1 0 0
2022/202397 1 0 4 0 2 0 1 0 76 0 13 0
2023/202476 2 4 7 7 4 1 15 1 13 14 8 0
Totale 336